137 related articles for article (PubMed ID: 33347636)
1. Benzodiazepines: Thinking outside the black box.
Pergolizzi JV; LeQuang JA; Raffa RB
J Clin Pharm Ther; 2021 Jun; 46(3):554-559. PubMed ID: 33347636
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
Cowart K; Worley M; Rouby NE; Sando K
Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
[No Abstract] [Full Text] [Related]
3. Changes in Australian Early-Career General Practitioners' Benzodiazepine Prescribing: a Longitudinal Analysis.
Magin P; Tapley A; Dunlop AJ; Davey A; van Driel M; Holliday E; Morgan S; Henderson K; Ball J; Catzikiris N; Mulquiney K; Spike N; Kerr R; Holliday S
J Gen Intern Med; 2018 Oct; 33(10):1676-1684. PubMed ID: 30039495
[TBL] [Abstract][Full Text] [Related]
4. The Value of the Black Box Warning in Dermatology.
Winterfield L; Vleugels RA; Park KK
J Drugs Dermatol; 2015 Jul; 14(7):660-6. PubMed ID: 26151780
[TBL] [Abstract][Full Text] [Related]
5. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
[TBL] [Abstract][Full Text] [Related]
6. Provider Patient-Sharing Networks and Multiple-Provider Prescribing of Benzodiazepines.
Ong MS; Olson KL; Cami A; Liu C; Tian F; Selvam N; Mandl KD
J Gen Intern Med; 2016 Feb; 31(2):164-171. PubMed ID: 26187583
[TBL] [Abstract][Full Text] [Related]
7. Opioid and Benzodiazepine Coprescribing in the United States Before and After US Food and Drug Administration Boxed Warning.
Zhang VS; Olfson M; King M
JAMA Psychiatry; 2019 Nov; 76(11):1208-1210. PubMed ID: 31532463
[TBL] [Abstract][Full Text] [Related]
8. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
[TBL] [Abstract][Full Text] [Related]
9. Influence of safety warnings on ESA prescribing among dialysis patients using an interrupted time series.
Thamer M; Zhang Y; Lai D; Kshirsagar O; Cotter D
BMC Nephrol; 2013 Aug; 14():172. PubMed ID: 23927675
[TBL] [Abstract][Full Text] [Related]
10. Outpatient benzodiazepine utilization in Croatia: drug use or misuse.
Delaš Aždajić M; Likić R; Aždajić S; Šitum M; Lovrić I; Štimac Grbić D
Int J Clin Pharm; 2019 Dec; 41(6):1526-1535. PubMed ID: 31595447
[TBL] [Abstract][Full Text] [Related]
11. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
Cadogan CA; Ryder SA
Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
[TBL] [Abstract][Full Text] [Related]
12. Benzodiazepine dependence and its treatment with low dose flumazenil.
Hood SD; Norman A; Hince DA; Melichar JK; Hulse GK
Br J Clin Pharmacol; 2014 Feb; 77(2):285-94. PubMed ID: 23126253
[TBL] [Abstract][Full Text] [Related]
13. Bringing greater transparency to "black box" warnings.
Buckley NA; Rossi S
Clin Toxicol (Phila); 2011 Jul; 49(6):448-51. PubMed ID: 21824055
[TBL] [Abstract][Full Text] [Related]
14. Stronger Boxed Warning for Benzodiazepines.
Aschenbrenner DS
Am J Nurs; 2021 Mar; 121(3):22-23. PubMed ID: 33625005
[TBL] [Abstract][Full Text] [Related]
15. Variation among states in prescribing of opioid pain relievers and benzodiazepines--United States, 2012.
Paulozzi LJ; Mack KA; Hockenberry JM
J Safety Res; 2014 Dec; 51():125-9. PubMed ID: 25453186
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Pre-marketing Factors to Predict Post-marketing Boxed Warnings and Safety Withdrawals.
Schick A; Miller KL; Lanthier M; Dal Pan G; Nardinelli C
Drug Saf; 2017 Jun; 40(6):497-503. PubMed ID: 28342075
[TBL] [Abstract][Full Text] [Related]
17. Ethical and Practical Considerations in Removing Black Box Warnings from Drug Labels.
Yeh JS; Sarpatwari A; Kesselheim AS
Drug Saf; 2016 Aug; 39(8):709-14. PubMed ID: 27000800
[TBL] [Abstract][Full Text] [Related]
18. Benzodiazepine Use in Older Adults: Dangers, Management, and Alternative Therapies.
Markota M; Rummans TA; Bostwick JM; Lapid MI
Mayo Clin Proc; 2016 Nov; 91(11):1632-1639. PubMed ID: 27814838
[TBL] [Abstract][Full Text] [Related]
19. Long-term benzodiazepine and Z-drugs use in England: a survey of general practice [corrected].
Davies J; Rae TC; Montagu L
Br J Gen Pract; 2017 Sep; 67(662):e609-e613. PubMed ID: 28716996
[TBL] [Abstract][Full Text] [Related]
20. Off-Label Prescribing of Psychotropic Medication, 2005-2013: An Examination of Potential Influences.
O'Brien PL; Cummings N; Mark TL
Psychiatr Serv; 2017 Jun; 68(6):549-558. PubMed ID: 28093058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
